{"denoms":[{"counts":[{"groupId":"BG000","value":"121"},{"groupId":"BG001","value":"19"},{"groupId":"BG002","value":"140"}],"units":"Participants"}],"groups":[{"description":"Patients with non-squamous NSCLC regardless of genomic alteration status (newly diagnosed or progressing on therapy)","id":"BG000","title":"A - NSCLC All Comers Regardless of Genomic Alteration Status"},{"description":"Patients with non-squamous NSCLC progressing on erlotinib, gefitinib, or afatinib","id":"BG001","title":"B - Progressing on EGFR Targeted Therapies"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"42","upperLimit":"94","value":"66"},{"groupId":"BG001","lowerLimit":"45","upperLimit":"85","value":"67"},{"groupId":"BG002","lowerLimit":"42","upperLimit":"94","value":"66"}]}],"title":"Age, years"}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Customized","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"61"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"71"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"60"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"69"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"91"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"103"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"4"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"27"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"33"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"14"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"18"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"8"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"74"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"83"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"25"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"31"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"117"},{"groupId":"BG001","value":"19"},{"groupId":"BG002","value":"136"}]}]}],"description":"Patients who received EGFR mutation testing on both their tissue and plasma samples.","paramType":"COUNT_OF_PARTICIPANTS","title":"EGFR Mutation Tested","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"115"},{"comment":"Patients enrolled in Arm B were only assessed for EGFR mutation testing.","groupId":"BG001","value":"NA"},{"comment":"Total not calculated because data are not available (NA) in one or more arms.","groupId":"BG002","value":"NA"}]}]}],"description":"Patients who received ALK (EML4-ALK fusion) mutation testing on both their tissue and plasma samples.","paramType":"COUNT_OF_PARTICIPANTS","title":"ALK-EML4 Fusion Mutation Tested","unitOfMeasure":"Participants"}]}